{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:09:30Z","timestamp":1780758570661,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86497-8","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T06:56:34Z","timestamp":1737356194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases"],"prefix":"10.1038","volume":"15","author":[{"given":"Anwar Ahmed","family":"Salim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kawasoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kubozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"86497_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B. & Castelli, W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561\u20131566 (1990).","journal-title":"N. Engl. J. Med."},{"key":"86497_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1253\/circj.CJ-13-0470","volume":"78","author":"J Ishikawa","year":"2014","unstructured":"Ishikawa, J., Ishikawa, S., Kario, K. & Jichi Medical School (JMS) Cohort Study Investigators Group. Levels of cornell voltage and cornell product for predicting cardiovascular and stroke mortality and morbidity in the general Japanese population. Circ. J. 78, 465\u2013475 (2014).","journal-title":"Circ. J."},{"key":"86497_CR3","first-page":"38","volume":"12","author":"MR Movahed","year":"2022","unstructured":"Movahed, M. R., Ramaraj, R., Manrique, C. & Hashemzadeh, M. Left ventricular hypertrophy is independently associated with all-cause mortality. Am. J. Cardiovasc. Dis. 12, 38\u201341 (2022).","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"86497_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/ajh\/hpy055","volume":"31","author":"K Tanaka","year":"2018","unstructured":"Tanaka, K. et al. Prognostic value of electrocardiographic left ventricular hypertrophy on cardiovascular risk in a non-hypertensive community-based population. Am. J. Hypertens. 31, 895\u2013901 (2018).","journal-title":"Am. J. Hypertens."},{"key":"86497_CR5","unstructured":"Mancia, G. et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J. Hypertens. 41, 1874\u20132071 (2023)."},{"key":"86497_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura, S. et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens. Res. 42, 1235\u20131481 (2019).","journal-title":"Hypertens. Res."},{"key":"86497_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/ajh\/hpx067","volume":"30","author":"CN Bang","year":"2017","unstructured":"Bang, C. N. et al. Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study. Am. J. Hypertens. 30, 914\u2013922 (2017).","journal-title":"Am. J. Hypertens."},{"key":"86497_CR8","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/ndt\/gfi190","volume":"20","author":"RE Schmieder","year":"2005","unstructured":"Schmieder, R. E. The role of non-haemodynamic factors of the genesis of LVH. Nephrol. Dial Transpl. 20, 2610\u20132612 (2005).","journal-title":"Nephrol. Dial Transpl."},{"key":"86497_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ijcard.2017.12.086","volume":"258","author":"E Gerdts","year":"2018","unstructured":"Gerdts, E. et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int. J. Cardiol. 258, 257\u2013261 (2018).","journal-title":"Int. J. Cardiol."},{"key":"86497_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.jhh.1001718","volume":"18","author":"E Gerdts","year":"2004","unstructured":"Gerdts, E. et al. Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study). J. Hum. Hypertens. 18, 417\u2013422 (2004).","journal-title":"J. Hum. Hypertens."},{"key":"86497_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/HJH.0b013e328364fb58","volume":"32","author":"C Cuspidi","year":"2014","unstructured":"Cuspidi, C., Rescaldani, M., Sala, C. & Grassi, G. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J. Hypertens. 32, 16\u201325 (2014).","journal-title":"J. Hypertens."},{"key":"86497_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4314\/gmj.v49i1.4","volume":"49","author":"M Jobe","year":"2015","unstructured":"Jobe, M. et al. Electrocardiographic left ventricular hypertrophy among gambian diabetes mellitus patients. Ghana. Med. J. 49, 19\u201324 (2015).","journal-title":"Ghana. Med. J."},{"key":"86497_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","volume":"46","author":"E Paoletti","year":"2005","unstructured":"Paoletti, E., Bellino, D., Cassottana, P., Rolla, D. & Cannella, G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am. J. Kidney Dis. 46, 320\u2013327 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"86497_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.numecd.2018.10.001","volume":"29","author":"CW Liu","year":"2019","unstructured":"Liu, C. W. et al. The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals. Nutr. Metab. Cardiovasc. Dis. 29, 30\u201338 (2019).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"86497_CR15","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1038\/s41598-021-86693-2","volume":"11","author":"P Viwatrangkul","year":"2021","unstructured":"Viwatrangkul, P. et al. Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, central Thailand. Sci. Rep. 11, 7083 (2021).","journal-title":"Sci. Rep."},{"key":"86497_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/HYPERTENSIONAHA.108.118026","volume":"53","author":"J Ishikawa","year":"2009","unstructured":"Ishikawa, J. et al. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension 53, 28\u201334 (2009).","journal-title":"Hypertension"},{"key":"86497_CR17","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1097\/HJH.0b013e32835726a3","volume":"30","author":"C Cuspidi","year":"2012","unstructured":"Cuspidi, C. et al. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review. J. Hypertens. 30, 2066\u20132073 (2012).","journal-title":"J. Hypertens."},{"key":"86497_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/01.HYP.35.1.13","volume":"35","author":"PM Okin","year":"2000","unstructured":"Okin, P. M. et al. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 35, 13\u201318 (2000).","journal-title":"Hypertension"},{"key":"86497_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12872-023-03083-4","volume":"23","author":"N Parsa","year":"2023","unstructured":"Parsa, N. et al. The prevalence of left ventricular hypertrophy associated with type-2 diabetes in Shiraz, Iran: a cross-sectional study. BMC Cardiovasc. Disord. 23, 88 (2023).","journal-title":"BMC Cardiovasc. Disord."},{"key":"86497_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","volume":"27","author":"A Levin","year":"1996","unstructured":"Levin, A., Singer, J., Thompson, C. R., Ross, H. & Lewis, M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am. J. Kidney Dis. 27, 347\u2013354 (1996).","journal-title":"Am. J. Kidney Dis."},{"key":"86497_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10741-010-9197-z","volume":"16","author":"S Taddei","year":"2011","unstructured":"Taddei, S., Nami, R., Bruno, R. M., Quatrini, I. & Nuti, R. Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail. Rev. 16, 615\u2013620 (2011).","journal-title":"Heart Fail. Rev."},{"key":"86497_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/01.HYP.0000161184.10873.ea","volume":"45","author":"F Viazzi","year":"2005","unstructured":"Viazzi, F. et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 45, 991\u2013996 (2005).","journal-title":"Hypertension"},{"key":"86497_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01535-0","author":"AA Salim","year":"2023","unstructured":"Salim, A. A. et al. Sex-specific associations between serum uric acid levels and risk of hypertension for different diagnostic reference values of high blood pressure. Hypertens. Res. https:\/\/doi.org\/10.1038\/s41440-023-01535-0 (2023).","journal-title":"Hypertens. Res."},{"key":"86497_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1253\/circj.CJ-08-0626","volume":"73","author":"H Mitsuhashi","year":"2009","unstructured":"Mitsuhashi, H. et al. Uric acid and left ventricular hypertrophy in Japanese men. Circ. J. 73, 667\u2013672 (2009).","journal-title":"Circ. J."},{"key":"86497_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1536\/ihj.13-170","volume":"55","author":"A Yoshimura","year":"2014","unstructured":"Yoshimura, A. et al. Serum uric acid is associated with the left ventricular mass index in males of a general population. Int. Heart J. 55, 65\u201370 (2014).","journal-title":"Int. Heart J."},{"key":"86497_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1253\/circj.70.885","volume":"70","author":"K Matsumura","year":"2006","unstructured":"Matsumura, K., Ohtsubo, T., Oniki, H., Fujii, K. & Iida, M. Gender-related association of serum uric acid and left ventricular hypertrophy in hypertension. Circ. J. 70, 885\u2013888 (2006).","journal-title":"Circ. J."},{"key":"86497_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003564","author":"E Gherbesi","year":"2023","unstructured":"Gherbesi, E. et al. Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies. J. Hypertens. https:\/\/doi.org\/10.1097\/HJH.0000000000003564 (2023).","journal-title":"J. Hypertens."},{"key":"86497_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.numecd.2012.01.007","volume":"23","author":"G Mul\u00e8","year":"2013","unstructured":"Mul\u00e8, G. et al. Absence of an independent association between serum uric acid and left ventricular mass in caucasian hypertensive women and men. Nutr. Metab. Cardiovasc. Dis. 23, 715\u2013722 (2013).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"86497_CR29","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1161\/CIRCULATIONAHA.108.191097","volume":"119","author":"EW Hancock","year":"2009","unstructured":"Hancock, E. W. et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 119, e251\u2013261 (2009).","journal-title":"Circulation"},{"key":"86497_CR30","unstructured":"World Health Organization: Waist circumference and waist-hip ratio: report of a WHO expert consultation. (2008)."},{"key":"86497_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","volume":"37","author":"M Sokolow","year":"1949","unstructured":"Sokolow, M. & Lyon, T. P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am. Heart J. 37, 161\u2013186 (1949).","journal-title":"Am. Heart J."},{"key":"86497_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.7143\/jhep.42.301","volume":"42","author":"W Ogawa","year":"2015","unstructured":"Ogawa, W. & Miyazaki, S. Diagnosis criteria for obesity and obesity disease. JAMHTS 42, 301\u2013306 (2015).","journal-title":"JAMHTS"},{"key":"86497_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53, 982\u2013992 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"86497_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/hr.2013.134","volume":"37","author":"R Yoshitomi","year":"2014","unstructured":"Yoshitomi, R. et al. Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease. Hypertens. Res. 37, 246\u2013252 (2014).","journal-title":"Hypertens. Res."},{"key":"86497_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/08037050701288255","volume":"16","author":"P Vottonen","year":"2007","unstructured":"Vottonen, P. et al. Electrocardiographic left ventricular hypertrophy has low diagnostic accuracy in middle-aged subjects. Blood Press. 16, 328\u2013334 (2007).","journal-title":"Blood Press."},{"key":"86497_CR36","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/HJH.0b013e32836040a4","volume":"31","author":"RL Antikainen","year":"2013","unstructured":"Antikainen, R. L. et al. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in the hypertension in the very elderly trial. J. Hypertens. 31, 1224\u20131232 (2013).","journal-title":"J. Hypertens."},{"key":"86497_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell, B. H. & Carabello, B. A. Left ventricular hypertrophy: Pathogenesis, detection, and prognosis. Circulation 102, 470\u2013479 (2000).","journal-title":"Circulation"},{"key":"86497_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jch.13136","volume":"20","author":"A Maloberti","year":"2018","unstructured":"Maloberti, A. et al. Sex-related relationships between uric acid and target organ damage in hypertension. J. Clin. Hypertens. 20, 193\u2013200 (2018).","journal-title":"J. Clin. Hypertens."},{"key":"86497_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","volume":"278","author":"T Maruhashi","year":"2018","unstructured":"Maruhashi, T., Hisatome, I., Kihara, Y. & Higashi, Y. Hyperuricemia and endothelial function: from molecular background to clinical perspectives. Atherosclerosis 278, 226\u2013231 (2018).","journal-title":"Atherosclerosis"},{"key":"86497_CR40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/HYPERTENSIONAHA.114.04737","volume":"65","author":"G Jia","year":"2015","unstructured":"Jia, G. et al. Uric acid promotes left ventricular diastolic dysfunction in mice fed a western diet. Hypertension 65, 531\u2013539 (2015).","journal-title":"Hypertension"},{"key":"86497_CR41","first-page":"8754","volume":"13","author":"K Gao","year":"2021","unstructured":"Gao, K. et al. High uric acid promotes mitophagy through the ROS\/CaMKII\u03b4\/Parkin pathway in cardiomyocytes in vitro and in vivo. Am. J. Transl. Res. 13, 8754\u20138765 (2021).","journal-title":"Am. J. Transl. Res."},{"key":"86497_CR42","first-page":"1894","volume":"12","author":"XJ Zhang","year":"2020","unstructured":"Zhang, X. J. et al. Potential risk of hyperuricemia: leading cardiomyocyte hypertrophy by inducing autophagy. Am. J. Transl. Res. 12, 1894\u20131903 (2020).","journal-title":"Am. J. Transl. Res."},{"key":"86497_CR43","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.amjhyper.2007.01.013","volume":"20","author":"C Cuspidi","year":"2007","unstructured":"Cuspidi, C. et al. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am. J. Hypertens. 20, 678\u2013685 (2007).","journal-title":"Am. J. Hypertens."},{"key":"86497_CR44","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","volume":"110","author":"RB Devereux","year":"2004","unstructured":"Devereux, R. B. et al. Regression of Hypertensive Left ventricular hypertrophy by Losartan compared with atenolol: the Losartan intervention for Endpoint reduction in hypertension (LIFE) trial. Circulation 110, 1456\u20131462 (2004).","journal-title":"Circulation"},{"key":"86497_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/jhh.2014.21","volume":"29","author":"H Ueda","year":"2015","unstructured":"Ueda, H., Miyawaki, M. & Hiraoka, H. High-normal blood pressure is associated with new-onset electrocardiographic left ventricular hypertrophy. J. Hum. Hypertens. 29, 9\u201313 (2015).","journal-title":"J. Hum. Hypertens."},{"key":"86497_CR46","doi-asserted-by":"crossref","unstructured":"Tian, X. et al. Association of Normal Serum Uric Acid Level and Cardiovascular Disease in People Without Risk Factors for Cardiac Diseases in China. JAHA 12, e029633 (2023).","DOI":"10.1161\/JAHA.123.029633"},{"key":"86497_CR47","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ki.2011.414","volume":"81","author":"A Parsa","year":"2012","unstructured":"Parsa, A. et al. Genotype-based changes in serum uric acid affect blood pressure. Kidney Int. 81, 502\u2013507 (2012).","journal-title":"Kidney Int."},{"key":"86497_CR48","doi-asserted-by":"crossref","unstructured":"Xiang, D., Liu, Y., Zhou, S., Zhou, E. & Wang, Y. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxid. Med. Cell. Longev. 2021, 5523516 (2021).","DOI":"10.1155\/2021\/5523516"},{"key":"86497_CR49","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/09513590.2015.1056730","volume":"31","author":"S Yu","year":"2015","unstructured":"Yu, S., Yang, H., Guo, X., Zheng, L. & Sun, Y. Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China. Gynecol. Endocrinol. 31, 736\u2013741 (2015).","journal-title":"Gynecol. Endocrinol."},{"key":"86497_CR50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0026-0495(98)90056-7","volume":"47","author":"CS Wingrove","year":"1998","unstructured":"Wingrove, C. S., Walton, C. & Stevenson, J. C. The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism 47, 435\u2013438 (1998).","journal-title":"Metabolism"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86497-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T06:58:38Z","timestamp":1737356318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86497-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86497"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86497-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2319"}}